INSIGHTS ON CRITICAL ENVIRONMENTS
-
![Quality inspection laboratory, research and development-GettyImages-2164156074]( "How To Inspect Used Stainless Steel Tanks And Reactors To Avoid Risk")
How To Inspect Used Stainless Steel Tanks And Reactors To Avoid RiskUsed stainless steel tanks can cut costs and lead times, but only with a thorough evaluation. Verify specifications, inspect welds and surfaces, and confirm dimensions to ensure reliable performance.
-
![Debunking Regulatory Myths In CGT Orphan Drug Development]( "Reducing The Bioburden Load In Drug Formulation And Filling")
Reducing The Bioburden Load In Drug Formulation And FillingSterile drug manufacturing requires preventing and removing contamination. Multi-stage filtration cuts microbial load, protects final filters, and supports quality, efficiency, and patient safety.
-
![Ecolab bioexpo]( "Optimize Every Step In Your Biopharma Site")
Optimize Every Step In Your Biopharma SiteBridge the gap between validation and cleanroom execution. Learn how proactive site surveys, residue management, and robust CAPA programs resolve compliance deficiencies and ensure audit readiness.
-
![Bio-Expo Live]( "MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing")
MilliporeSigma Bio-Expo Live February 2025: Downstream BioprocessingAdvancements in single-use technologies are transforming antibody-drug conjugate manufacturing and offering increased flexibility. Examine key data, design considerations, operational benefits, and applications in ADC production.
-
Maintain Control Of Pharmaceutical Water Systems4/10/2026
Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.
-
Syntegon Virtual Pharma Expo May 2025: Aseptic Manufacturing And Packaging5/21/2025
The 2022 EU GMP Annex 1 revision marks a pivotal shift in sterile manufacturing, emphasizing contamination control, advanced technologies, and global harmonization—driving industry-wide adaptation and regulatory interpretation challenges.
-
Insights Into Evionnaz's new R&D Center9/23/2026
Pharmaceutical innovation depends on speed and smarter decisions. Discover how advanced R&D technologies and real-time insights are helping accelerate development.
-
Pharmaceutical Requirements For Portable Monitoring In Cleanrooms3/5/2026
Maintain rigorous pharmaceutical cleanroom standards through strategic environmental monitoring. Explore essential guidelines for particle detection and effective data analysis to ensure compliance.
-
PDA TR33 And The Case For Rapid Methods In H₂O₂ Bio-Decontamination10/14/2026
The updated 2026 PDA Technical Report No. 33 offers a framework for qualifying alternative and rapid microbiological methods against traditional standards for regulatory compliance.
CRITICAL ENVIRONMENT SOLUTIONS
-
![Aseptic Filling GettyImages-1087219366]( "Drug Product Fill Finish And Formulation Solutions")
Formulation and aseptic filling solutions are crucial at every stage of development. Consider a manufacturing partner who can address every challenge on the path from pre-clinical programs to commercialization.
-
![tsi]( "FMS 5 Facility Monitoring Software For Life Science Applications")
Benefits of TSI's unique FMS 5 product offering.
-
![LaserPro]( "Pharmaceutical Airborne Particle Counter: Lasair® Pro")
Innovative portable particle counter meeting all regulatory requirements.
-
TSI AeroTrak+ Remote Particle Counters offer cleanroom professionals top-notch reliability and no-hassle operation in measuring a wide range of particle sizes, including a 6-channel model with upper size threshold of 25 µm.
-
![Cytiva Kubio]( "Modular Environments For Biomanufacturing Capacity")
Accelerate your biomanufacturing capacity with purpose-built modules
KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.
FREE CLEANING VALIDATION E-BOOK
Learn how to employ science-, risk-, and statistics-based approaches to cleaning and cleaning validation at your facility with this free, 100-page e-book, written by a global team of cleaning validation experts, pharmaceutical toxicologists, statisticians, and Six Sigma professionals.
